Structure of human endothelial nitric oxide synthase heme domain in complex with (S)-6-(3-fluoro-5-(2-(pyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine

Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.

Endothelial nitric oxide synthase splice variant eNOS13A

12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3
10% glycerol, 5 mM TCEP

National Institutes of Health/National Cancer Institute (NIH/NCI)

Nitric oxide synthase, endothelial (E.C.1.14.13.39)

nitric oxide synthase inhibitor complex heme enzyme, OXIDOREDUCTASE, OXIDOREDUCTASE-OXIDOREDUCTASE inhibitor complex